181 related articles for article (PubMed ID: 33227299)
1. Potential disturbance of methylphenidate of gonadal hormones or pubescent development in patients with attention-deficit/hyperactivity disorder: A twelve-month follow-up study.
Wang LJ; Huang YH; Chou WJ; Lee SY; Tsai CS; Lee MJ; Chou MC
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jun; 108():110181. PubMed ID: 33227299
[TBL] [Abstract][Full Text] [Related]
2. Mullerian inhibiting substance, sex hormone binding globulin and sex hormone levels in stimulant-naïve, first-diagnosed prepubertal boys with attention-deficit/hyperactivity disorder: comparison with matched healthy controls as well as before and after oros-methylpenidate treatment.
Gokcen C; Erbagci AB; Mutluer T; Orkmez M; Correll CU
Int J Psychiatry Clin Pract; 2019 Nov; 23(4):251-257. PubMed ID: 31339400
[No Abstract] [Full Text] [Related]
3. Effect of methylphenidate on the onset of puberty and reproductive organ development in rats.
Khoubbieh F; Erdogan CS; Onel T; Yildirim E; Sumer E; Yaba A; Yilmaz B
Physiol Behav; 2023 Jul; 266():114204. PubMed ID: 37086829
[TBL] [Abstract][Full Text] [Related]
4. Testicular Function After Long-Term Methylphenidate Treatment in Boys with Attention-Deficit/Hyperactivity Disorder.
Wang LJ; Lee SY; Chou WJ; Lee MJ; Tsai CS; Lee TL; Yang CJ; Yang KC; Chen CK; Shyu YC
J Child Adolesc Psychopharmacol; 2019 Aug; 29(6):433-438. PubMed ID: 30575416
[No Abstract] [Full Text] [Related]
5. Effects of methylphenidate on body index and physical fitness in Korean children with attention deficit hyperactivity disorder.
Kang KD; Yun SW; Chung U; Kim TH; Park JH; Park IH; Han DH
Hum Psychopharmacol; 2016 Mar; 31(2):76-82. PubMed ID: 26756111
[TBL] [Abstract][Full Text] [Related]
6. Growth Hormone and Thyroid Function in Children With Attention Deficit Hyperactivity Disorder Undergoing Drug Therapy.
Wang LJ; Huang YH; Chou WJ; Lee SY
J Clin Endocrinol Metab; 2022 Jun; 107(7):2047-2056. PubMed ID: 35262170
[TBL] [Abstract][Full Text] [Related]
7. Does Methylphenidate Reduce Testosterone Levels in Humans? A Prospective Study in Children with Attention-Deficit/Hyperactivity Disorder.
Wang LJ; Chou MC; Chou WJ; Lee MJ; Lin PY; Lee SY; Lee YH
Int J Neuropsychopharmacol; 2017 Mar; 20(3):219-227. PubMed ID: 27816940
[TBL] [Abstract][Full Text] [Related]
8. No elevated genomic damage in children and adolescents with attention deficit/hyperactivity disorder after methylphenidate therapy.
Walitza S; Kämpf K; Artamonov N; Romanos M; Gnana Oli R; Wirth S; Warnke A; Gerlach M; Stopper H
Toxicol Lett; 2009 Jan; 184(1):38-43. PubMed ID: 19015014
[TBL] [Abstract][Full Text] [Related]
9. Osmotic Release Oral System Methylphenidate Versus Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder in Chinese Youth: 8-Week Comparative Efficacy and 1-Year Follow-Up.
Su Y; Yang L; Stein MA; Cao Q; Wang Y
J Child Adolesc Psychopharmacol; 2016 May; 26(4):362-71. PubMed ID: 26779845
[TBL] [Abstract][Full Text] [Related]
10. Remission in children and adolescents diagnosed with attention-deficit/hyperactivity disorder via an effective and tolerable titration scheme for osmotic release oral system methylphenidate.
Chou WJ; Chen SJ; Chen YS; Liang HY; Lin CC; Tang CS; Huang YS; Yeh CB; Chou MC; Lin DY; Hou PH; Wu YY; Liu HJ; Huang YF; Hwang KL; Chan CH; Pan CH; Chang HL; Huang CF; Hsu JW
J Child Adolesc Psychopharmacol; 2012 Jun; 22(3):215-25. PubMed ID: 22537358
[TBL] [Abstract][Full Text] [Related]
11. Long-term neurocognitive effects of methylphenidate in patients with attention deficit hyperactivity disorder, even at drug-free status.
Huang YS; Wang LJ; Chen CK
BMC Psychiatry; 2012 Nov; 12():194. PubMed ID: 23140464
[TBL] [Abstract][Full Text] [Related]
12. A post hoc comparison of the effects of lisdexamfetamine dimesylate and osmotic-release oral system methylphenidate on symptoms of attention-deficit hyperactivity disorder in children and adolescents.
Soutullo C; Banaschewski T; Lecendreux M; Johnson M; Zuddas A; Anderson C; Civil R; Higgins N; Bloomfield R; Squires LA; Coghill DR
CNS Drugs; 2013 Sep; 27(9):743-51. PubMed ID: 23801529
[TBL] [Abstract][Full Text] [Related]
13. An expert opinion on methylphenidate treatment for attention deficit hyperactivity disorder in pediatric patients with epilepsy.
Baptista-Neto L; Dodds A; Rao S; Whitney J; Torres A; Gonzalez-Heydrich J
Expert Opin Investig Drugs; 2008 Jan; 17(1):77-84. PubMed ID: 18095920
[TBL] [Abstract][Full Text] [Related]
14. Association of Parkinson's disease with symptoms of attention deficit hyperactivity disorder in childhood.
Walitza S; Melfsen S; Herhaus G; Scheuerpflug P; Warnke A; Müller T; Lange KW; Gerlach M
J Neural Transm Suppl; 2007; (72):311-5. PubMed ID: 17982908
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of Methylphenidate Hydrochloride Extended-Release Capsules (Aptensio XR™) in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Phase III, Randomized, Double-Blind Study.
Wigal SB; Nordbrock E; Adjei AL; Childress A; Kupper RJ; Greenhill L
CNS Drugs; 2015 Apr; 29(4):331-40. PubMed ID: 25877989
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and Safety of HLD200, Delayed-Release and Extended-Release Methylphenidate, in Children with Attention-Deficit/Hyperactivity Disorder.
Pliszka SR; Wilens TE; Bostrom S; Arnold VK; Marraffino A; Cutler AJ; López FA; DeSousa NJ; Sallee FR; Incledon B; Newcorn JH
J Child Adolesc Psychopharmacol; 2017 Aug; 27(6):474-482. PubMed ID: 29172680
[TBL] [Abstract][Full Text] [Related]
17. Randomized, Double-Blind, Placebo-Controlled Acute Comparator Trials of Lisdexamfetamine and Extended-Release Methylphenidate in Adolescents With Attention-Deficit/Hyperactivity Disorder.
Newcorn JH; Nagy P; Childress AC; Frick G; Yan B; Pliszka S
CNS Drugs; 2017 Nov; 31(11):999-1014. PubMed ID: 28980198
[TBL] [Abstract][Full Text] [Related]
18. Improvement of attention deficit/hyperactivity disorder (ADHD) in three adult men during testosterone treatment: a case series.
Rogne A; Hassel B
J Med Case Rep; 2022 Nov; 16(1):425. PubMed ID: 36397172
[TBL] [Abstract][Full Text] [Related]
19. Effects of extended release methylphenidate treatment on ratings of attention-deficit/hyperactivity disorder (ADHD) and associated behavior in children with autism spectrum disorders and ADHD symptoms.
Pearson DA; Santos CW; Aman MG; Arnold LE; Casat CD; Mansour R; Lane DM; Loveland KA; Bukstein OG; Jerger SW; Factor P; Vanwoerden S; Perez E; Cleveland LA
J Child Adolesc Psychopharmacol; 2013 Jun; 23(5):337-51. PubMed ID: 23782128
[TBL] [Abstract][Full Text] [Related]
20. Methylphenidate-related growth impairment.
Holtkamp K; Peters-Wallraf B; Wüller S; Pfäaffle R; Herpertz-Dahlmann B
J Child Adolesc Psychopharmacol; 2002; 12(1):55-61. PubMed ID: 12014596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
